the atypical antipsychotic drug, nulloxin, is a highly effective and safe antipsychotic that is a promising strategy for treating patients with schizophrenia and other disorders. in this article, we present our experience with the development of a new molecule and its potential benefits. we also discuss the current status of our research and research efforts.